Industry conferences seem to bring out the best in participants as different entities come together to support and learn from one another. The close-knit medtech ecosystem is no exception, as entrepreneurs and industry leaders attended the recent MedTech Strategist Innovation Summit in San Francisco, united in their mission to advance patient care.
CyberHeart, a startup that is developing the world’s first non-invasive treatment for cardiac arrhythmias, has experienced tremendous clinical successes in the past few months.
“This is a game changer,” (for patients with irregular heart rhythm), said Dr. Melvin Scheinman, a professor of medicine at the University of California, San Francisco, and past president of the Heart Rhythm Society,
Like many successful medtech entrepreneurs and Ferolyn Fellows, Shreya Mehta has a passion and knack for building and finding solutions to challenging and unsolved problems — skills which led her to co-found and launch Zenflow.
At the Fogarty Institute we depend on our board of seasoned professionals to help us continue to grow and adapt to the medtech market. That’s why we were delighted to add another elite name to our esteemed group, with Stacy Enxing Seng joining as our newest member. With nearly 30 years of experience in the medtech industry,
Seminar Reviews the Importance of Clinical Evidence and Health Economics in Getting to Market
Many medical device entrepreneurs believe that the single most important milestone to achieve in gaining market adoption of their technology is regulatory approval. While certainly an essential step, it is often not sufficient.